Progenitor and lymphoma cells in blood stem cell harvests: Impact on survival following transplantation

A. Demirkazik, A. Kessinger, James Olen Armitage, Philip Jay Bierman, J. Lynch, Julie Marie Vose, W. Chan, John G Sharp

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

This study evaluated whether cytokine-induced blood stem cell mobilization also mobilized lymphoma cells and whether lymphoma cell mobilization affected outcome post autologous blood stem cell transplant. Blood stem cell collections from 26 non-Hodgkin's lymphoma (NHL) patients harvested during steady-state (non-mobilized) and from 35 NHL patients harvested after cytokine administration (mobilized) were studied. The harvests were cultured and molecularly evaluated for clonal markers of the primary lymphoma. All patients underwent high-dose chemotherapy and autologous transplantation. Graft products from mobilized patients were more likely to contain lymphoma than graft products from non-mobilized patients (37% vs 19%) but this difference was not significant (P=0.16). In a multivariate analysis, lymphoma contamination was not associated with patient age, gender, tumor grade, prior radiotherapy, duration of prior chemotherapy, mononuclear cell count, or the number of aphereses performed to obtain the product. Heavily pre-treated patients were less likely to have lymphoma-contaminated harvests (P=0.064). Lymphoma contamination was positively associated with the number of progenitor cells collected (P = 0.047). In multivariate analyses, the only significant independent predictor of lymphoma contamination was the number of mononuclear cells collected (P=0.031). Lymphoma contamination of transplanted apheresis products had no apparent impact on event-free and overall survival.

Original languageEnglish (US)
Pages (from-to)207-212
Number of pages6
JournalBone marrow transplantation
Volume28
Issue number2
DOIs
StatePublished - Aug 20 2001

Fingerprint

Lymphoma
Blood Cells
Stem Cells
Transplantation
Survival
Blood Component Removal
Transplants
Non-Hodgkin's Lymphoma
Multivariate Analysis
Cell Count
Hematopoietic Stem Cell Mobilization
Cytokines
Drug Therapy
Autologous Transplantation
Disease-Free Survival
Radiotherapy
Neoplasms

Keywords

  • Blood stem cell transplant
  • Lymphoma
  • Micrometastases
  • Mobilization

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Progenitor and lymphoma cells in blood stem cell harvests : Impact on survival following transplantation. / Demirkazik, A.; Kessinger, A.; Armitage, James Olen; Bierman, Philip Jay; Lynch, J.; Vose, Julie Marie; Chan, W.; Sharp, John G.

In: Bone marrow transplantation, Vol. 28, No. 2, 20.08.2001, p. 207-212.

Research output: Contribution to journalArticle

@article{ceff41adb4d246a096cc31fe0ada38a3,
title = "Progenitor and lymphoma cells in blood stem cell harvests: Impact on survival following transplantation",
abstract = "This study evaluated whether cytokine-induced blood stem cell mobilization also mobilized lymphoma cells and whether lymphoma cell mobilization affected outcome post autologous blood stem cell transplant. Blood stem cell collections from 26 non-Hodgkin's lymphoma (NHL) patients harvested during steady-state (non-mobilized) and from 35 NHL patients harvested after cytokine administration (mobilized) were studied. The harvests were cultured and molecularly evaluated for clonal markers of the primary lymphoma. All patients underwent high-dose chemotherapy and autologous transplantation. Graft products from mobilized patients were more likely to contain lymphoma than graft products from non-mobilized patients (37{\%} vs 19{\%}) but this difference was not significant (P=0.16). In a multivariate analysis, lymphoma contamination was not associated with patient age, gender, tumor grade, prior radiotherapy, duration of prior chemotherapy, mononuclear cell count, or the number of aphereses performed to obtain the product. Heavily pre-treated patients were less likely to have lymphoma-contaminated harvests (P=0.064). Lymphoma contamination was positively associated with the number of progenitor cells collected (P = 0.047). In multivariate analyses, the only significant independent predictor of lymphoma contamination was the number of mononuclear cells collected (P=0.031). Lymphoma contamination of transplanted apheresis products had no apparent impact on event-free and overall survival.",
keywords = "Blood stem cell transplant, Lymphoma, Micrometastases, Mobilization",
author = "A. Demirkazik and A. Kessinger and Armitage, {James Olen} and Bierman, {Philip Jay} and J. Lynch and Vose, {Julie Marie} and W. Chan and Sharp, {John G}",
year = "2001",
month = "8",
day = "20",
doi = "10.1038/sj.bmt.1703124",
language = "English (US)",
volume = "28",
pages = "207--212",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Progenitor and lymphoma cells in blood stem cell harvests

T2 - Impact on survival following transplantation

AU - Demirkazik, A.

AU - Kessinger, A.

AU - Armitage, James Olen

AU - Bierman, Philip Jay

AU - Lynch, J.

AU - Vose, Julie Marie

AU - Chan, W.

AU - Sharp, John G

PY - 2001/8/20

Y1 - 2001/8/20

N2 - This study evaluated whether cytokine-induced blood stem cell mobilization also mobilized lymphoma cells and whether lymphoma cell mobilization affected outcome post autologous blood stem cell transplant. Blood stem cell collections from 26 non-Hodgkin's lymphoma (NHL) patients harvested during steady-state (non-mobilized) and from 35 NHL patients harvested after cytokine administration (mobilized) were studied. The harvests were cultured and molecularly evaluated for clonal markers of the primary lymphoma. All patients underwent high-dose chemotherapy and autologous transplantation. Graft products from mobilized patients were more likely to contain lymphoma than graft products from non-mobilized patients (37% vs 19%) but this difference was not significant (P=0.16). In a multivariate analysis, lymphoma contamination was not associated with patient age, gender, tumor grade, prior radiotherapy, duration of prior chemotherapy, mononuclear cell count, or the number of aphereses performed to obtain the product. Heavily pre-treated patients were less likely to have lymphoma-contaminated harvests (P=0.064). Lymphoma contamination was positively associated with the number of progenitor cells collected (P = 0.047). In multivariate analyses, the only significant independent predictor of lymphoma contamination was the number of mononuclear cells collected (P=0.031). Lymphoma contamination of transplanted apheresis products had no apparent impact on event-free and overall survival.

AB - This study evaluated whether cytokine-induced blood stem cell mobilization also mobilized lymphoma cells and whether lymphoma cell mobilization affected outcome post autologous blood stem cell transplant. Blood stem cell collections from 26 non-Hodgkin's lymphoma (NHL) patients harvested during steady-state (non-mobilized) and from 35 NHL patients harvested after cytokine administration (mobilized) were studied. The harvests were cultured and molecularly evaluated for clonal markers of the primary lymphoma. All patients underwent high-dose chemotherapy and autologous transplantation. Graft products from mobilized patients were more likely to contain lymphoma than graft products from non-mobilized patients (37% vs 19%) but this difference was not significant (P=0.16). In a multivariate analysis, lymphoma contamination was not associated with patient age, gender, tumor grade, prior radiotherapy, duration of prior chemotherapy, mononuclear cell count, or the number of aphereses performed to obtain the product. Heavily pre-treated patients were less likely to have lymphoma-contaminated harvests (P=0.064). Lymphoma contamination was positively associated with the number of progenitor cells collected (P = 0.047). In multivariate analyses, the only significant independent predictor of lymphoma contamination was the number of mononuclear cells collected (P=0.031). Lymphoma contamination of transplanted apheresis products had no apparent impact on event-free and overall survival.

KW - Blood stem cell transplant

KW - Lymphoma

KW - Micrometastases

KW - Mobilization

UR - http://www.scopus.com/inward/record.url?scp=0034903640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034903640&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1703124

DO - 10.1038/sj.bmt.1703124

M3 - Article

C2 - 11509940

AN - SCOPUS:0034903640

VL - 28

SP - 207

EP - 212

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 2

ER -